Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0272
Source ID: NCT03223883
Associated Drug: Curcumin
Title: Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT03223883/results
Conditions: Chronic Kidney Diseases|Cognitive Decline
Interventions: DRUG: Curcumin|OTHER: Placebo
Outcome Measures: Primary: Change in Vascular Endothelial Function at 12 Months, Brachial artery flow-mediated dilation, changed in diameter in brachial artery in response to shear stress, 12 months | Secondary: Large Artery Stiffness, Aortic pulse wave velocity, 12 months|Cognitive Function, NIH toolbox battery- Executive Function Age-Corrected Standard Score is reported (T-score): This score compares the score of the test-taker to those in the NIH Toolbox nationally representative normative sample at the same age, where a score of 100 indicates performance that was at the national average for the test-taking participant's age. Age-corrected standard scores were derived separately for children (ages 3-17) and adults (ages 18-85). A score of 115 or 85, for example, would indicate that the participant's performance is 1 SD above or below the national average, respectively, when compared with like-aged participants. Higher scores indicate better performance., 12 months
Sponsor/Collaborators: Sponsor: Diana Jalal | Collaborators: University of Colorado, Boulder|Stanford University|University of Colorado, Denver
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 94
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2018-06-01
Completion Date: 2023-01-25
Results First Posted: 2024-10-08
Last Update Posted: 2024-10-08
Locations: University of Iowa, Iowa City, Iowa, 52242, United States
URL: https://clinicaltrials.gov/show/NCT03223883